CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Conceptus, Inc. is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Conceptus, Inc.
331 East Evelyn Avenue
Phone: (650) 962-4000p:650 962-4000 MOUNTAIN VIEW, CA  94041  United States Ticker: CPTSCPTS

This company was Merged or Acquired on 6/4/2013.
This company ceased filing statements with the SEC on 6/17/2013.
This company is no longer actively traded on any major stock exchange.
This is a Subsidiary, click here for the Parent Company

Business Summary
Conceptus, Inc. designs, develops, markets and promotes solutions in women’s healthcare. The Company’s flagship product is the Essure permanent birth control procedure, which is the non-surgical permanent birth control system. The Essure delivers a soft and flexible insert into a woman’s fallopian tubes, causing a benign tissue in-growth, which blocks the fallopian tubes. Successfully placed Essure inserts and the subsequent tissue growth around, and through the inserts prohibits the egg from traveling through the fallopian tube, preventing conception. In October 2011, the Company acquired from its Dutch distributor certain assets and all distribution rights of the Essure device. In October 2011, it purchased certain assets of Sigma Medical and established a wholly owned subsidiary in the Netherlands, Conceptus B.V. (BV). During the year ended December 31, 2011, approximately 600,000 women worldwide have undergone the Essure procedure.
(Source: 10-K)

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
3/31/201312/31/2012YesYes--Yes

Industries
SIC Code Description
3841 Surgical and medical instruments and apparatus

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
President, Chief Executive Officer D. KeithGrossman 52 6/5/2013 12/8/2011
Chief Financial Officer, Treasurer Gregory E.Lichtwardt 1/21/2013 11/17/2003
Executive Vice President, Chief Compliance Officer, General Counsel, Corporate Secretary Julie A.Brooks 66 2/1/2010 11/1/2009
9 additional Officers and Directors records available in full report.

Business Names
Business Name
Conceptus BV
Conceptus Costa Rica, S.R.L.
Conceptus Medical Limited
Conceptus SAS
Conceptus, Inc.
CPTS

General Information
Number of Employees: 286 (As of 12/31/2012)
Outstanding Shares: 32,429,695 (As of 5/1/2013)
Shareholders: 88
Stock Exchange: NASD
Federal Tax Id: 943170244
Fax Number: (650) 962-5200
Email Address: IR@conceptus.com


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, July 21, 2023